Back to 
Point72 Asset Management, L.P.
Point72 Asset Management, L.P.
KRYS
Showing 0 of 19 quarters
Position history for Point72 Asset Management, L.P.'s holdings in Krystal Biotech, Inc.
No. Point72 Asset Management exited its KRYS (Krystal Biotech) position in Q1 2024. Its Q4 2023 13F listed 15,299 shares worth $1.9M. Point72 Asset Management first reported KRYS in Q1 2019 and held it in 17 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.